BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16767933)

  • 1. Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique.
    Kusamura S; Deraco M; Baratti D; Inglese MG; Costanzo P; Favaro M; Manzi R; Gavazzi C
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):207-12. PubMed ID: 16767933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
    Kusamura S; Younan R; Baratti D; Costanzo P; Favaro M; Gavazzi C; Deraco M
    Cancer; 2006 Mar; 106(5):1144-53. PubMed ID: 16456817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma.
    Deraco M; De Simone M; Rossi CR; Cavaliere F; Difilippo F; Scuderi S; Pilatti P; Kusamura S
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):41-5. PubMed ID: 16767905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei.
    Deraco M; De Simone M; Rossi CR; Cavaliere F; Di Filippo F; Vaira M; Piatti P; Kusamura S
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):35-9. PubMed ID: 16767904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
    Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
    Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.
    Deraco M; Casali P; Inglese MG; Baratti D; Pennacchioli E; Bertulli R; Kusamura S
    J Surg Oncol; 2003 Jul; 83(3):147-53. PubMed ID: 12827682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity.
    Kusamura S; Baratti D; Younan R; Laterza B; Oliva GD; Costanzo P; Favaro M; Gavazzi C; Grosso F; Deraco M
    Ann Surg Oncol; 2007 Sep; 14(9):2550-8. PubMed ID: 17558537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kusamura S; Baratti D; Antonucci A; Younan R; Laterza B; Oliva GD; Gavazzi C; Deraco M
    Ann Surg Oncol; 2007 Dec; 14(12):3443-52. PubMed ID: 17909918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
    Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
    Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.
    Cavaliere F; Di Filippo F; Botti C; Cosimelli M; Giannarelli D; Aloe L; Arcuri E; Aromatario C; Consolo S; Callopoli A; Laurenzi L; Tedesco M; Di Angelo P; Giunta S; Cavaliere R
    Eur J Surg Oncol; 2000 Aug; 26(5):486-91. PubMed ID: 11016471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Czech experience in peritonectomy and hyperthermic perioperative cytostatic lavage in the treatment of peritoneal malignancy].
    Antos F; Serclova Z; Gilbert Z; Skala M; Vitek P
    Zentralbl Chir; 2004 Apr; 129(2):153-6. PubMed ID: 15106050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion.
    Younan R; Kusamura S; Baratti D; Oliva GD; Costanzo P; Favaro M; Gavazzi C; Deraco M
    Ann Surg Oncol; 2005 Nov; 12(11):910-8. PubMed ID: 16177862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
    Baratti D; Pennacchioli E; Kusamura S; Fiore M; Balestra MR; Colombo C; Mingrone E; Gronchi A; Deraco M
    Ann Surg Oncol; 2010 Dec; 17(12):3220-8. PubMed ID: 20585874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
    Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
    Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) in the treatment of pseudomyxoma peritonei: ten years experience in a single center.
    Deraco M; Kusamura S; Laterza B; Favaro M; Fumagalli L; Costanzo P; Baratti D
    In Vivo; 2006; 20(6A):773-6. PubMed ID: 17203766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
    Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
    Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study.
    Gilly FN; Beaujard A; Glehen O; Grandclement E; Caillot JL; Francois Y; Sadeghi-Looyeh B; Gueugniaud PY; Garbit F; Benoit M; Bienvenu J; Vignal J
    Anticancer Res; 1999; 19(3B):2317-21. PubMed ID: 10472351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies.
    Kusamura S; Baratti D; Deraco M
    Ann Surg; 2012 Feb; 255(2):348-56. PubMed ID: 22202584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.